This is great news for all suffering from painful bouts of migraine. The Food and Drug Administration (FDA) recently approved the first of a new class of medications for treating migraine. The drug is called Emgality and is made by drug giant Eli Lilly, highlighted a recent media report. The same report revealed that until May, no approved drugs for alleviating migraines were available. However, other treatments like Botox and anti-seizure medications have also been used. Not just these, pain relievers can also help cure some of the migraine symptoms. This drug and its competitors target calcitonin gene-related peptide (CGRP).